ELISPOT assay of the SARS-CoV-2 specific T cells immune response
The COVID-19 pandemic has stimulated interest in the development of biotechnology, as well as in the search for new solutions in the diagnostics of immune processes. The response of immunoglobulins A, M and G had a significant role in the assessment of virus-specific immune responses. Later, it was...
Saved in:
Main Authors: | V. V. Gerasimova, S. V. Kolesnik, D. A. Kudlay, A. S. Golderova |
---|---|
Format: | Article |
Language: | Russian |
Published: |
Scientific Сentre for Family Health and Human Reproduction Problems
2022-12-01
|
Series: | Acta Biomedica Scientifica |
Subjects: | |
Online Access: | https://www.actabiomedica.ru/jour/article/view/3829 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Cell-mediated and humoral immunity during COVID-19 in the Republic of Crimea
by: E. Yu. Zyablitskaya, et al.
Published: (2023-03-01) -
Assessment of T-cell immunity to SARS-CoV-2 in COVID-19 convalescents and vaccinated subjects, using TigraTest<sup>®</sup> SARS-CoV-2 ELISPOT kit
by: D. A. Poteryaev, et al.
Published: (2021-10-01) -
Comparison of different techniques for evaluation of cellular immunity to SARS-CoV-2 virus
by: Z. E. Afridonova, et al.
Published: (2023-11-01) -
Prospects for Using the ELISPOT Technological Platform as Part of Anti-Epidemic Measures Against the New Coronavirus Infection COVID-19
by: D. A. Poteryaev, et al.
Published: (2020-09-01) -
Features of the functioning of B-2 lymphocytes in patients with common variable immune deficiency in post-vaccination immunity to SARS-CoV-2
by: L. P. Sizyakina, et al.
Published: (2023-07-01)